Novo Nordisk is expanding its cash-only savings program offering its blockbuster weight-loss drug Wegovy for $499 a month at all U.S. pharmacies. 23andMe has filed for Chapter 11 bankruptcy protection with CEO Anne Wojcicki stepping down to help with a sale. And the U.S. Department of Health and Human Services (HHS)…
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Cheaper Wegovy, 23andMe shutters, and RFK Jr. cuts FDA jobs: Pharma news roundup )
Also on site :
- Men have hundreds more saved in ‘rainy day’ funds than women, research indicates
- Trump announces U.S.-China trade talks in London
- China consumer prices slump again, deepening deflation worries as demand stays weak